Biphasic Insulin Aspart 50 (BIAsp 50)

biphasic insulin aspart 50 · Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Biphasic Insulin Aspart 50 (BIAsp 50), covering 2017-02-24 to 2017-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Subjects [Phase 1]